Aesthetic Medicine

Company reports additional FDA clearances for its Gemini system

Published in Medical Letter on the CDC and FDA, May 9th, 2004

The U.S. Food and Drug Administration (FDA) has cleared Laserscope's (LSCP) Gemini laser system for three major additional indications, including acne treatment, permanent hair reduction, and wrinkle reduction.

Including these new clearances, Laserscope's Gemini laser system is FDA-cleared to perform 21 total procedures.

"We are very pleased and excited with this news, and believe the three new FDA clearances validate the tremendous versatility of the Gemini product platform," said Eric Reuter, Laserscope's president and CEO. "Using the Gemini, a physician can now perform over 90% of all aesthetic laser procedures currently available in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry